NYSE:BMYPharmaceuticals
Bristol-Myers Squibb Earnings Strength And Pipeline Shape Future Valuation
Bristol-Myers Squibb (NYSE:BMY) reported strong fourth quarter earnings, supported by a growth portfolio that includes several products now generating more than $1b in annual sales.
The company highlighted upcoming pivotal pipeline readouts that could influence its future product mix and long term revenue profile.
Bristol-Myers Squibb announced recent business moves, including the acquisition of Orbital Therapeutics, a collaboration with BioNTech, and plans for a new research facility.
These...